Effect of generic-only drug benefits on seniors' medication use and financial burden.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Managed Care

• Publication date

  2006-09-01

• Fields of study

  Medicine, Economics

• Identifiers
  PMID 16961441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential Savings From Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997-2000

  2006cited by this paper
• Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit.

  2005cited by this paper
• Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit

  2004cited by this paper
• Effects of generic-only drug coverage in a Medicare HMO.

  2004cited by this paper
• Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.

  2004cited by this paper
• Medicare+Choice Plans Continue to Shift More Costs to Enrollees. The Commonwealth Fund

  2003cited by this paper
• Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

  2003influential reference
• The effect of incentive-based formularies on prescription-drug utilization and spending.

  2003cited by this paper
• Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers

  2003cited by this paper
• Exploring Generic Drug Use Behavior: The Role of Prescribers and Pharmacists in the Opportunity for Generic Drug Use and Generic Substitution

  2002cited by this paper
• A prescription for drug cost savings

  2002cited by this paper
• Employer drug benefit plans and spending on prescription drugs.

  2002cited by this paper
• Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

  2002cited by this paper
• A physician survey on generic drugs and substitution of critical dose medications.

  1997cited by this paper
• Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.

  1987cited by this paper
• Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.

  1987cited by this paper

• Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes - A systematic review.

  2020cites this paper
• Impact of Mood Disorder on Medication Adherence in Patients with Chronic Diseases at a Shanghai Rural Hospital

  2015cites this paper
• Generic medication utilization policies in the United States and Medicaid sustainability

  2015cites this paper
• Does Increased Use of Generic Medicines by Elders in Belgium Help to Contain Escalating Health Care Budgets?

  2014cites this paper
• Medication persistence and the use of generic and brand-name blood pressure-lowering agents

  2014cites this paper
• Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.

  2014cites this paper
• Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.

  2011cites this paper
• Generic substitution of commonly used medications: Australia‐wide experience, 2007–2008

  2010cites this paper
• Copayment Level and Drug Switching: Findings for Type 2 Diabetes

  2010cites this paper
• Medication adherence and use of generic drug therapies.

  2009cites this paper
• The Demise of Oregon’s Medically Needy Program: Effects of Losing Prescription Drug Coverage

  2007cites this paper
• The Demise of Oregon’s Medically Needy Program: Effects of Losing Prescription Drug Coverage

  2007cites this paper
• Effects of a Physician Office Generic Drug Sampling System on Generic Dispensing Ratios and Drug Costs in a Large Managed Care Organization

  2007cites this paper
• Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

  2007cites this paper